|
1
|
Prentki M and Nolan CJ: Islet beta cell
failure in type 2 diabetes. J Clin Invest. 116:1802–1812. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rhodes CJ: Type 2 diabetes-a matter of
beta-cell life and death? Science. 307:380–384. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Azuma K, Kawamori R, Toyofuku Y, Kitahara
Y, Sato F, Shimizu T, Miura K, Mine T, Tanaka Y, Mitsumata M and
Watada H: Repetitive fluctuations in blood glucose enhances
monocyte adhesion to the endothelium of rat thoracic aorta.
Arterioscler Thromb Vasc Biol. 26:2275–2280. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sun LQ, Chen YY, Wang X, Li XJ, Xue B, Qu
L, Zhang TT, Mu YM and Lu JM: The protective effect of alpha lipoic
acid on Schwann cells exposed to constant or intermittent high
glucose. Biochem Pharmacol. 84:961–973. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kohnert KD, Freyse EJ and Salzsieder E:
Glycaemic variability and pancreatic β-cell dysfunction. Curr
Diabetes Rev. 8:345–354. 2012.
|
|
6
|
Holz GG and Chepurny OG: Diabetes outfoxed
by GLP-1? Sci STKE. 268:pe22005.PubMed/NCBI
|
|
7
|
Tschen SI, Dhawan S, Gurlo T and Bhushan
A: Age-dependent decline in beta-cell proliferation restricts the
capacity of beta-cell regeneration in mice. Diabetes. 58:1312–1320.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Baggio LL and Drucker DJ: Biology of
incretins: GLP-1 and GIP. Gastroenterology. 132:2131–2157. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Okada T, Liew CW, Hu J, Hinault C, Michael
MD, Krtzfeldt J, Yin C, Holzenberger M, Stoffel M and Kulkarni RN:
Insulin receptors in beta-cells are critical for islet compensatory
growth response to insulin resistance. Proc Natl Acad Sci USA.
104:8977–8982. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim MJ, Kang JH, Park YG, Ryu GR, Ko SH,
Jeong IK, Koh KH, Rhie DJ, Yoon SH, Hahn SJ, Kim MS and Jo YH:
Exendin-4 induction of cyclin D1 expression in INS-1 beta-cells:
involvement of cAMP-responsive element. J Endocrinol. 188:623–633.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song WJ, Schreiber WE, Zhong E, Liu FF,
Kornfeld BD, Wondisford FE and Hussain MA: Exendin-4 stimulation of
cyclin A2 in beta-cell proliferation. Diabetes. 57:2371–2381. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhan Y, Sun HL, Chen H, Zhang H, Sun J,
Zhang Z and Cai DH: Glucagon-like peptide-1 (GLP-1) protects
vascular endothelial cells against advanced glycation end products
(AGEs)-induced apoptosis. Med Sci Monit. 18:BR286–BR291. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mwitari PG, Ayeka PA, Ondicho J, Matu EN
and Bii CC: Antimicrobial activity and probable mechanisms of
action of medicinal plants of Kenya: Withania somnifera, Warbugia
ugandensis, Prunus africana and Plectrunthus barbatus. PloS One.
8:e656192013. View Article : Google Scholar
|
|
14
|
Zhang T, Tan Y, Zhao R and Liu Z: DNA
damage induced by oridonin involves cell cycle arrest at G2/M phase
in human MCF-7 cells. Contemp Oncol (Pozn). 17:38–44.
2013.PubMed/NCBI
|
|
15
|
Tschen SI, Dhawan S, Gurlo T and Bhushan
A: Age-dependent decline in beta-cell proliferation restricts the
capacity of beta-cell regeneration in mice. Diabetes. 58:1312–1320.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kim W and Egan JM: The role of incretins
in glucose homeostasis and diabetes treatment. Pharmacol Rev.
60:470–512. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Drucker DJ: Glucagon-like peptides:
regulators of cell proliferation, differentiation, and apoptosis.
Mol Endoerinol. 17:161–171. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Portha B, Tourrel-Cuzin C and Movassat J:
Activation of the GLP-1 receptor signaling pathway: a relevant
strategy to repair a deficient beta-cell mass. Exp Diabetes Res.
2011:3765092011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Drucker DJ: Incretin-based therapy and the
quest for sustained improvements in β-cell health. Diabetes Care.
34:2133–2135. 2011.PubMed/NCBI
|
|
20
|
Feanny MA, Fagan SP, Ballian N, Liu SH, Li
Z, Wang X, Fisher W, Brunicardi FC and Belaguli NS: PDX-1
expression is associated with islet proliferation in vitro and in
vivo. J Surg Res. 144:8–16. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bicknell KA, Surry EL and Brooks G:
Targeting the cell cycle machinery for the treatment of
cardiovascular disease. J Pharm Pharmacol. l55:571–591. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pines J: Cyclin-dependent kinase
inhibitors: the age of crystals. Biochim Biophys Acta.
1332:M39–M42. 1997.PubMed/NCBI
|
|
23
|
Porter PL, Malone KE, Heagerty PJ,
Alexander GM, Gatti LA, Firpo EJ, Daling JR and Roberts JM:
Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and
in combination, correlate with survival in young breast cancer
patients. Nat Med. 3:222–225. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Carrano AC, Eytan E, Hershko A and Pagano
M: SKP2 is required for ubiquitin-mediated degradation of the CDK
inhibitor p27. Nat Cell Biol. 1:193–199. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bornstein G, Bloom J, Sitry-Shevah D,
Nakayama K, Pagano M and Hershko A: Role of the SCFSkp2 ubiquitin
ligase in the degradation ofp21Cip1 in S phase. J Biol Chem.
278:25752–25757. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Frödin M, Sekine N, Roche E, Filloux C,
Prentki M, Wollheim CB and Van Obberghen E: Glucose, other
secretagogues, and nerve growth factor stimulate mitogen-activated
protein kinase in the insulin-secreting β-cell line, INS-1. J Biol
Chem. 270:7882–7889. 1995.PubMed/NCBI
|
|
27
|
List JF and Habener JF: Glucagon-like
peptide 1 agonists and the development and growth of pancreatic
β-cells. Am J Physiol Endocrinol Metab. 286:E875–E881. 2004.
|
|
28
|
Susini S, Roche E, Prentki M and Schlegel
W: Glucose and glucoincretin peptides synergize to induce c-fos,
c-jun, junB, zif-268, and nur-77 gene expression in pancreatic
beta(INS-1) cells. FASEB J. 12:1173–1182. 1998.PubMed/NCBI
|
|
29
|
Kang JH, Kim MJ, Ko SH, Jeong IK, Koh KH,
Rhie DJ, Yoon SH, Hahn SJ, Kim MS and Jo YH: Upregulation of rat
Ccnd1 gene by exendin-4 in pancreatic beta cell line INS-1:
interaction of early growth response-1 with cis-regulatory element.
Diabetologia. 49:969–979. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Friedrichsen BN, Neubauer N, Lee YC, Gram
VK, Blume N, Petersen JS, Nielsen JH and Møldrup A: Stimulation of
pancreatic-cell replication by incretins involves transcriptional
induction of cyclin D1 via multiple signalling pathways.
Endocrinol. 188:481–492. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kossatz U, Dietrich N, Zender L, Buer J,
Manns MP and Malek NP: Skp2-dependent degradation of p27kip1 is
essential for cell cycle progression. Genes Dev. 18:2602–2607.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Frouin I, Montecucco A, Biamonti G,
Hübscher U, Spadari S and Maga G: Cell cycle-dependent dynamic
association of cyclin/Cdk complexes with human DNA replication
proteins. EMBO J. 21:2485–2495. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tschen SI, Georgia S, Dhawan S and Bhushan
A: Skp2 is required for incretin hormone-mediated β-cell
proliferation. Mol Endocrinol. 25:2134–43. 2011.PubMed/NCBI
|
|
34
|
Sherr CJ and Roberts JM: CDK inhibitors:
positive and negative regulators of G1-phase progression. Genes
Dev. 13:1501–1512. 1999. View Article : Google Scholar : PubMed/NCBI
|
